Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Archive Search

1 results
3:22 PM, Jan 26, 2017  |  BC Innovations | Strategy

Deep roots

In a New England Journal of Medicine study published last March, the partners showed inactivating ANGPTL4
from the Geisinger cohort were associated with decreased triglyceride levels and risk of CAD. An anti-ANGPTL4
Euronext:SAN; NYSE:SNY), Paris, France Vanderbilt University, Nashville, Tenn. Targets and Compounds  ANGPTL3 - Angiopoietin-like 3 ANGPTL4